(Q40772938)

23 September 2017

title

Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201. (English)

1 reference

23 September 2017

D F Smee

1 reference

23 September 2017

R W Sidwell

1 reference

23 September 2017

A C Morrison

1 reference

23 September 2017

K W Bailey

1 reference

23 September 2017

E Z Baum

1 reference

23 September 2017

L Ly

1 reference

23 September 2017

P C Wagaman

1 reference

23 September 2017

publication date

1 December 2001

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

251-259

1 reference

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

The gene structure and replication of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Resistance of influenza viruses to neuraminidase inhibitors--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900168-1

7 January 2021

10.1016/S0166-3542(01)00168-1

Identifiers

DOI

1 reference

23 September 2017

1 reference